Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Leiomyosarcoma
  • Uterine Neoplasms

abstract

  • Fixed-dose rate gemcitabine plus docetaxel achieves high objective response rates as first-line therapy in metastatic uterine leiomyosarcoma.

publication date

  • June 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2504727

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2008.03.010

PubMed ID

  • 18534250

Additional Document Info

start page

  • 329

end page

  • 34

volume

  • 109

number

  • 3